Filter news by category :
Edinburgh Molecular Imaging is part of an EPSRC funded consortium, led by Dr Jon Shephard of Heriot-Watt University in collaboration with Professor David Jayne from the University of Leeds to develop a revolutionary new bowel cancer surgery tool that will enable surgeons to carry out operations...
On 12th May, EM Imaging took part to the EIE16 investor showcase (http://www.eie-invest.com/), along with 60 companies across the Life Sciences, Energy and ICT sectors. With more than 900 guests, the event was an absolute success. EM Imaging had the opportunity to pitch in front of potential...
Edinburgh and Paris, April 6th, 2016 – Edinburgh Molecular Imaging Ltd (EM Imaging) and Mauna Kea Technologies (Euronext: MKEA, OTCQX: MKEAY) today announced a clinical research collaboration to study the potential of combining EM Imaging’s in vivo optical imaging agents and Mauna Kea's...
Edinburgh Molecular imaging Ltd (EM Imaging) announced today that the company has received a SBRI Stratified Medicine Connecting the UK Infrastructure Phase I grant from the UK’s innovation agency, Innovate UK. The SBRI grant aims to accelerate and increase the development and adoption of...
EM Imaging has been selected as one of the 14 teams that will Pitch on Monday 7th March, 2016 at St. James's Palace. In addition, there will be a Peoples Choice vote and we would appreciate if our followers could vote for us at the following link. ow.ly/YI6dN
Edinburgh Molecular Imaging have been announced as finalists at the Duke of York’s 'Pitch at the Palace' competition, which is designed to help entrepreneurs develop their business ideas. The team will pitch to HRH Duke of York and 300 business people at St James’s Palace on 7...
Edinburgh, United Kingdom, 16 th September, 2015 - Edinburgh Molecular Imaging Ltd. (EM Imaging) has signed an exclusive global license for a novel optical imaging agent that could improve the detection of early-stage colorectal (bowel) cancer. EM Imaging, a company which develops and...
Edinburgh, United Kingdom, 2nd September 2015 - The Board of Edinburgh Molecular Imaging Ltd (EM Imaging) is pleased to announce the appointment of John Jeans CBE CEng as non-executive Chairman with effect from 31st August 2015. In an industrial career spanning 35 years John held senior...
Human neutrophil elastase (HNE) is a serine protease implicated in the pathogenesis of acute and chronic inflammatory disease. Here a series of, internally quenched, single fluorophore fluorescent reporters were synthesised that allowed the rapid, highly specific and sensitive analysis...